Stephen K Ames, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 840 Sw 4th Avenue, Suite 105, Ontario, OR 97914 Phone: 541-881-2380 Fax: 541-881-2389 |
Dr. Paola Andrea D'aleman Poveda, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1219 Sw 4th Ave Unit 1, Ontario, OR 97914 Phone: 541-889-2668 |
Nora Francisco De La Paz, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 932 W Idaho Ave Ste 101, Ontario, OR 97914 Phone: 541-889-6476 Fax: 541-889-7403 |
Mrs. Sandra Dunbrasky, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1219 Sw 4th Ave, Suite 1, Ontario, OR 97914 Phone: 541-889-2668 Fax: 541-889-2997 |
Kevin Francis Wade, M.D. Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 1219 Sw 4th Ave, Ontario, OR 97914 Phone: 541-889-2668 Fax: 541-889-2997 |
Dr. Thomas Kent Geraci, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1219 Sw 4th Ave, Suite 1, Ontario, OR 97914 Phone: 541-889-2668 |
News Archive
A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine - or tailoring treatment for individual people - can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference, today (Friday).
Two drugs tested in a larger trial did not improve kidney function in acute heart failure patients, contrary to results of smaller studies. The results were presented today at the American Heart Association's Scientific Sessions 2013 in Dallas and simultaneously published in the Journal of the American Medical Association. Previous smaller studies showed that low-dose dopamine or low-dose nesiritide could improve kidney function and reduce fluid overload that is often present in hospitalized acute heart failure patients by increasing urine production.
A molecule that helps cells stick together is significantly over-produced in two very different diseases - rheumatoid arthritis and a variety of cancers, including breast and brain tumors, concludes a new study. The scientists who made the discovery also found candidate drugs to inhibit the molecule, cadherin-11, one of which is already in a clinical trial.
AAPC Physician Services, a practice management solutions provider, announces the launch of its medical auditing service line based on feedback from physicians and a strong demand for industry expertise.
› Verified 4 days ago